Animal Health News & Notes for June 29, 2018

***********************************
Brakke Consulting’s
Animal Health News & Notes for June 29, 2018
Copyright © Brakke Consulting, Inc.

Editor: Lynn Fondon DVM MBA
************************************
IN THE NEWS:

Brakke Consulting news
Market research
Veterinary Practice Home Delivery report

earnings news
Premier Veterinary Group

other news
Avivagen
CannPal Animal Therapeutics
Centauri Biotech
Cure Partners
Global Stem cell Technology
ImmuCell
Kindred Biosciences
LiveDVM
Neogen
Patterson Veterinary
Technology Partner Innovations
Veterinary Practice Partners
Zoetis – Fostera Gold
Zoetis – Suvaxyn Circo

***********************************
BRAKKE CONSULTING, INC.
MARKET RESEARCH SERVICES
Look Before You Leap

Depend on Brakke Consulting to meet your company’s market research needs, whether it is:

• Assessing the feasibility of a new product or technology
• Identifying the opinions and trends of veterinarians, pet owners or producers
• Determining the current market for products

With our in-house database of veterinarians and the ability to custom-tailor surveys of a wide variety of target audiences, we provide reliable insights into this unique industry. We also produce multiclient reports in a number of high-interest animal health market areas. For more information, see our website or call our Dallas office at 972-243-4033.

www.BrakkeConsulting.com

***********************************
COMPANY EARNINGS RELEASES

• Premier Veterinary Group PLC reported financial results for the second fiscal quarter ended March 31, 2018. Revenues were GBP 1.54 million ($2.2 million), an increase of 12% compared to the prior-year quarter. Net loss for the quarter was GBP (1.9) million ($2.7 million). (Wall Street Journal)

**********************************
BRAKKE CONSULTING, INC.
VETERINARY PRACTICE HOME DELIVERY REPORT
NOW AVAILABLE

Pharmacy sales represent an important component of a veterinary clinic’s revenues. In today’s competitive environment, veterinarians increasingly need to offer innovative, convenient solutions to successfully compete with online pet pharmacies and retail sources.

Developed from the data collected for Brakke’s biannual 2017 Distributor Effectiveness Study, the Veterinary Practice Home Delivery Report contains key information about companion animal veterinarians’ approach to providing the convenience in purchasing veterinary products demanded by their clients. The report, based on data from over 1,100 companion animal practice respondents, includes regional and practice size data analysis in addition to the national aggregate data. It answers questions such as:
• How are veterinarians serving clients who prefer to order products online or by telephone?
• What are the trends in writing prescriptions for online pharmacies?
• How many clinics have online stores, and what is the sales volume through the stores?
• Which online services providers are clinics utilizing, what are their market shares, and how do veterinarians rate their performance?

The Veterinary Practice Home Delivery Report is now available for $8,900.

For more information, contact Lynn Fondon at lfondon@brakkeconsulting.com.

www.BrakkeConsulting.com

**********************************
COMPANY NEWS RELEASES

• Zoetis announced it has received approval from the USDA to begin marketing Fostera Gold PCV, a monovalent vaccine for swine that includes two genotypes of porcine circovirus type 2 — 2a and 2b. The new vaccine follows the March launch of Fostera Gold PCV MH, which contains the same two PCV genotypes, but also protects against Mycoplasma hyopneumoniae. (National Hog Farmer)

• Patterson Veterinary announced a joint venture with Cure Partners, a leading provider of practice management software and services. Together the companies have formed a new business, Technology Partner Innovations, LLC, which is launching a new cloud-based practice management software, NaVetor. (company press release)

• Neogen Corporation announced that its Acumedia and Lab M products are being combined and rebranded as Neogen Culture Media. Neogen acquired Acumedia in 2000 and England-based Lab M in 2015. (company press release)

• ImmuCell Corporation announced it will join the Russell Microcap Index at the conclusion of the Russell US Indexes annual reconstitution, effective after the U.S. market opens on June 25, 2018. (company press release)

• Kindred Biosciences reported it has closed its public offering of shares and raised $50.6 million. KindredBio offered 4,631,578 shares of common stock at a public price of $9.50 per share, raising $44 million. Additionally, underwriters exercised their option to purchase an additional 694,736 shares of KindredBio’s common stock at $9.50 per share, adding $6.6 million to the proceeds. (Animal Pharm)

• Veterinary Practice Partners announced its 50th veterinary hospital partnership. (Veterinary Practice News)

• A new service called LiveDVM is offering pet owners phone call, text or video appointments for a $49.95 fee. LiveDVM seeks to reinforce the veterinarian-client-patient relationship (VCPR) by providing off-hours service that directs clients straight back to their own provider. Doctors sign up to take shifts in their off hours to answer calls from clients. When a client calls, the LiveDVM service matches that person with a doctor from their own practice, when one is available. When the client is matched with a veterinarian who’s not their own, the doctor follows a protocol that is designed to educate the pet owner and suggest hypothetical scenarios. (DVM360)

• EU Zoetis announced the European launch of Suvaxyn Circo vaccine against porcine circovirus type 2 (PCV2) for protection of pigs over the age of three weeks against the virus for a duration of 23 weeks. (Animal Pharm)

• CANADA Avivagen Inc. announced that the Veterinary Drugs Directorate of Health Canada has added Fully Oxidized beta-Carotene to the Veterinary Health Product (VHP) list of substances and designated it for oral use in cats and dogs. (company press release)

• EU The European Medicines Agency’s Committee for Medicinal Products for Veterinary Use has recommended Global Stem cell Technology’s (GST) Arti-Cell Forte, the only stem cell veterinary medicine to date to receive marketing authorization in the EU. The therapy is indicated for the reduction of mild to moderate lameness linked to joint inflammation in horses. (Animal Pharm)

• EU Centauri Biotech’s Horse Allo 20 stem-cell based product has received a negative opinion ruling from the European medicines Agency’s Committee for Medicinal Products for Veterinary Use (CVMP). The CVMP said its grounds for a negative opinion “relate to quality, safety and efficacy issues”. (Animal Pharm)

• AUSTRALIA CannPal Animal Therapeutics announced a research agreement with the Commonwealth Scientific and Industrial Research Organization, Australia’s national science agency. CannPal will work with CSIRO to look at the use of food production technologies to enhance cannabis-derived therapeutics in companion animals. CannPal will receive A$50,000 (US$36,700) in funding to contribute towards the research project. (Animal Pharm)

***********************************
ANIMAL HEALTH NEWS

• EU – PPR The Bulgarian Food Safety Agency has discovered the first case of the highly contagious disease peste des petits ruminants (PPR) on livestock farms in the village of Voden, close to the Turkish border. This is the first time the disease has been detected in Bulgaria as well as in the European Union. National authorities have imposed a 3km quarantine zone around the affected village, ordering clinical examinations of the animals within 10km from the outbreak, and banning trade and transport of all livestock in the regions bordering Turkey. (Animal Pharm)

• US – FDA GUIDANCE The FDA has released Guidance for Industry #252, entitled “Antimicrobial Animal Drug Sales and Distribution Reporting Small Entity Compliance Guide.” This small entity compliance guide (SECG) is intended to help small businesses comply with the Antimicrobial Animal Drug Sales and Distribution final rule. For more information, go to https://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm612041.htm?utm_campaign=6-28-2018-GFI252&utm_medium=email&utm_source=Eloqua. (FDA)

• EU – REGULATION DISCUSSIONS Regulatory authorities from the US and Europe have reasserted the goal of introducing a mutual recognition agreement (MRA) to the veterinary medicines industry no later than July 2019. A US-EU MRA on pharmaceutical inspections with good manufacturing practices (GMP) came into operation in November 2017 for the human medicines sector, which authorities aim to have by July 15, 2019. (Animal Pharm)

************************************
BRAKKE CONSULTING VIEWPOINT

This is the last business day of the second quarter of 2018. In a few days the public companies will be providing their results for the first half of the year. In various interfaces with executives this past week, we are under the impression that business remains strong for most companies. However, we are hearing some concerns over the competitiveness in some large product categories.

What is probably more alarming is the current weather throughout the US. It is hot and dry in some areas to the point where stress on animals and forage supply could become a problem. Another area of concern is the political scene where confusing trade agreements and/or tariffs could disrupt the flow of animal protein to some of the US producers’ leading customers. It is not only the short-term impact, but also with some of these conflicts we run the risk of the US not being competitive for some period of time, which results in reduce profits and number of animal being produced. Let’s hope common sense political decisions prevail in the long term.

In the US, next Wednesday, July 4th, is our Annual Independence Day. Have a safe holiday and consume extra amounts of animal protein during the week. Also, stay cool – which might be the biggest challenge of the holiday!

Ron Brakke

**********************************
This electronic newsletter is the sole property of Brakke Consulting, Inc.
Any use of the contents herein should be approved by and appropriately attributed to Brakke Consulting, Inc.

For more information about Brakke Consulting’s services and syndicated studies, visit our website at www.brakkeconsulting.com.

Brakke Consulting, Inc.
12005 Ford Rd., Suite 530
Dallas, TX 75234 USA